Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05645705 · ClinicalTrials.gov registry record · Phase 4
A Two-Week Study of Clinical Safety and Saliva Flow Quantification
A Phase 4 study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- Phase 4
- Development phase
- 270
- Enrollment target
NCT05645705 is a Phase 4 study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 270 participants.
The verdict
NCT05645705, a Phase 4 study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 270 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the oral tissue tolerance (tissues within the mouth) for irritation caused by added ingredients in mouthwashes. This will be assessed based on oral tissue exams and adverse reactions.
Interventions
- OTHER Colgate Cavity Protection Toothpaste
- OTHER LISTERINE Cool Mint Antiseptic Mouthwash
- OTHER Listerine Advanced Gum Alcohol
- OTHER Listerine Advanced Gum Zero
- OTHER LISTERINE ULTRACLEAN Tartar Control Antiseptic Mouthwash Cool Mint
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2022-11-28 |
| Est. Completion | 2022-12-16 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05645705
The ClinicalTrials.gov registry entry for NCT05645705 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Colgate Cavity Protection Toothpaste is the first listed.
NCT05645705 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05645705 about?
NCT05645705 is a clinical study titled "A Two-Week Study of Clinical Safety and Saliva Flow Quantification". The purpose of this study is to assess the oral tissue tolerance (tissues within the mouth) for irritation caused by added ingredients in mouthwashes. This will be assessed based on oral tissue exams and adverse reactions.
What is the current status of trial NCT05645705?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 270 participants. The study started on 2022-11-28. Estimated completion is 2022-12-16.
What interventions are being tested in trial NCT05645705?
The interventions under investigation include: Colgate Cavity Protection Toothpaste (OTHER), LISTERINE Cool Mint Antiseptic Mouthwash (OTHER), Listerine Advanced Gum Alcohol (OTHER), Listerine Advanced Gum Zero (OTHER), LISTERINE ULTRACLEAN Tartar Control Antiseptic Mouthwash Cool Mint (OTHER).
Who is sponsoring clinical trial NCT05645705?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.